Concr
concr.co
Medical AI
Precision Medicine
Drug Discovery AI
As featured in
Claim pageClaim
Follow
Overview
Connections
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Latest round
Venture round
Mar 2025 · 19 mo ago
Grants
$737k
2 grants · CORDIS
Backers
3
Cambridge Enterprise, Cambridge Angels
The money's age
Due for its next round
19 months since the last round · not hiring
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Mar 24, 2025
Raised a round Venture round
Aug 12, 2024
Raised a round Venture round
Jan 1, 2024
Won a grant $498k · CORDIS
Sep 15, 2023
Raised a round Venture round
May 5, 2023
Raised a round Venture round
Nov 11, 2021
Raised a round Venture round
Apr 7, 2021
Raised a round Venture round
Jul 1, 2020
Won a grant $239k · CORDIS
2020
Founded
Apr 24, 2018
Incorporated CONCR LTD · Companies House
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Mar 2025 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Aug 2024 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Jan 2024 | $498k | — | CORDIS |
| Venture round | Sep 2023 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | May 2023 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Nov 2021 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Apr 2021 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Jul 2020 | $239k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | CONCR LTD | Companies House |
| Registered | 24 Apr 2018 |
Backed byfrom the funds' portfolios and accelerator catalogs
Cambridge Angels Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Panakeia is a London medical technology company founded in 2018 that predicts molecular tumour profiles from routine pathology slides. Its…
Ataraxis AI is a medical artificial intelligence company that builds foundation models for cancer care. Its first product, Ataraxis Breast…
DoMore Diagnostics is on a mission to transform cancer diagnostics with artificial intelligence to improve patient care and make drug…
Sano’s end-to-end precision medicine platform de-risks trials, enabling clinical operations teams to move 10x faster and reduce cost by 5x.
By testing the response of a patient’s own cancer cells against many treatment options, we help physicians and patients make truly informed…
Cellworks fuses mechanistic biology, clinical guidelines, and 300M+ patient records to model individual drug response for BioPharma and…
Overview
Concr is a London biotechnology company founded in 2020 that models tumour biology to predict how patients will respond to cancer drugs. Its FarrSight platform simulates treatment on virtual patients so that trial designs and prescribing decisions can be tested computationally. The company works with pharmaceutical developers and clinical research groups.
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Regulating complexity in AI-enabled omics and multi-omics technologies for precision medicine
The convergence of (multi-)omics and artificial intelligence is transforming precision medicine by enabling data-driven diagnostics, treatment prediction, and patient stratification. Yet, regulatory frameworks lag behind this innovation. This commentary d
Read more
Report
CariGenetics Partners With Concr Tech Firm
Concr - which was described as a "deeptech company dedicated to enabling precision medicine and improving drug development using predictive analytics and artificial intelligence AI" - announced its partnership with CariGenetics. A spokesperson said,
Read more
Report
Bayesian Digital Twins Show Potential For Predicting Prognosis And Treatment Response
Learn how Bayesian digital twins are trained, validated, and trusted in clinical settings and explore the potential for integrating these models into interventional trials.
Read more
Report
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
London
United Kingdom
HQ
Investors
Regent House, 316a Beulah Hill, London, SE19 3HF
Financials
Total raised
$737k
Latest round
Venture - Series Unknown
Funding rounds
8
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2025 | — | Details |
| Venture - Series Unknown | 2024 | — | Details |
| Grant | 2024 | $498k | Details |
| Venture - Series Unknown | 2023 | — | Details |
| Venture - Series Unknown | 2023 | — | Details |
| Venture - Series Unknown | 2021 | — | Details |
| Venture - Series Unknown | 2021 | — | Details |
| Grant | 2020 | $239k | Details |